5-p-Benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase
Abstract
The title compound (1), designed as a suicide inhibitor of thymidylate synthetase, can be prepared by silver(II) oxide oxidative demethylation of the corresponding dimethoxyphenyl derivative. Compound 1 shows time-dependent inactivation of thymidylate synthetase (methotrexate-resistant Lactobacillus casei) and saturation kinetics, and the inactivation is responsive to substrate protection. The inactivation is not reversible on prolonged dialysis in attempts to remove the inhibitor. The rate constant for inactivation is 0.065 s-1; the dissociation constant (Ki) was estimated to be 2 microM. The kinetics of this inactivation are compared to inactivation caused by model thiol reagents that do not have affinity for the active site of thymidylate synthetase.
Related Papers
- → Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward?(2008)95 cited
- → Tumor Cell Responses to Inhibition of Thymidylate Synthase(1988)6 cited
- → Enhancement of thymidylate synthase inhibition(1993)5 cited
- Current status of thymidylate synthase inhibitors in cancer therapy(2005)
- → The therapeutic efficacy of thymidylate synthase on pemetrexed treatment of lung adenocarcinoma(2017)